Filing Details
- Accession Number:
- 0000899243-21-027729
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-07-06 21:40:10
- Reporting Period:
- 2021-07-01
- Accepted Time:
- 2021-07-06 21:40:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1060736 | Seagen Inc. | SGEN | Biological Products, (No Disgnostic Substances) (2836) | 911874389 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1167496 | B Clay Siegall | 21823 30Th Drive Se Bothell WA 98021 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-07-01 | 3,432 | $15.46 | 718,641 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-07-01 | 3,432 | $158.64 | 715,209 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-07-01 | 6,165 | $15.46 | 721,374 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-07-01 | 6,165 | $157.92 | 715,209 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-07-01 | 4,488 | $15.46 | 719,697 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-07-01 | 4,488 | $156.94 | 715,209 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-07-02 | 310 | $15.46 | 715,519 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-07-02 | 310 | $158.29 | 715,209 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-07-02 | 2,355 | $15.46 | 717,564 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-07-02 | 2,355 | $157.31 | 715,209 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-07-02 | 7,412 | $15.46 | 722,621 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-07-02 | 7,412 | $156.43 | 715,209 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-07-02 | 5,191 | $15.46 | 720,400 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-07-02 | 5,191 | $155.70 | 715,209 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2021-07-01 | 3,432 | $0.00 | 3,432 | $15.46 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2021-07-01 | 6,165 | $0.00 | 6,165 | $15.46 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2021-07-01 | 4,488 | $0.00 | 4,488 | $15.46 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2021-07-02 | 310 | $0.00 | 310 | $15.46 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2021-07-02 | 2,355 | $0.00 | 2,355 | $15.46 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2021-07-02 | 7,412 | $0.00 | 7,412 | $15.46 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2021-07-02 | 5,191 | $0.00 | 5,191 | $15.46 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 55,274 | 2021-08-24 | No | 4 | M | Direct | |
| 49,109 | 2021-08-24 | No | 4 | M | Direct | |
| 44,621 | 2021-08-24 | No | 4 | M | Direct | |
| 44,311 | 2021-08-24 | No | 4 | M | Direct | |
| 41,956 | 2021-08-24 | No | 4 | M | Direct | |
| 34,544 | 2021-08-24 | No | 4 | M | Direct | |
| 29,353 | 2021-08-24 | No | 4 | M | Direct |
Footnotes
- Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $158.30 to $159.12. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $157.30 to $158.28. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $156.30 to $157.29 The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $158.06 to $158.41 The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $157.03 to $157.93. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $156.03 to $157.02. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $155.02 to $156.01 The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Options vested at a rate of 25% on 8/24/12 and monthly thereafter until all the options were fully vested on 8/24/15.
Billionaire Hedge Funds
